Why Do Weight Loss Drugs Fall Short in Diabetic Patients? Unraveling The Paradox

Editorial Letter

Why Do Weight Loss Drugs Fall Short in Diabetic Patients? Unraveling The Paradox

Swarup K. Chakrabarti ID ^*

H. P. Ghosh Research Center, New Town, Kolkata, West Bengal 700161, India.

*Corresponding Author: Swarup K. Chakrabarti, H. P. Ghosh Research Center, New Town, Kolkata, West Bengal 700161, India.

Citation: Chakrabarti SK. (2026). Why Do Weight Loss Drugs Fall Short in Diabetic Patients? Unraveling The Paradox, Clinical Case Reports and Studies, BioRes Scientia Publishers. 12(5):1-3. DOI: 10.59657/2837-2565.brs.26.326

Copyright: © 2026 Swarup K. Chakrabarti, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: April 01, 2026 | Accepted: April 20, 2026 | Published: April 30, 2026

Abstract

Weight Loss in Type 2 Diabetes: A Clinical Paradox

Keywords: weight loss; drugs; diabetic patients

Introduction

Incretin-based medications, especially GLP-1 receptor agonists (GLP-1RAs) and newer dual agonists (GLP-1/GIP), have fundamentally transformed the pharmacological management of obesity in recent years [1]. Despite this progress, a persistent paradox remains: while non-diabetic patients generally experience substantial weight loss with GLP-1RAs, patients with type 2 diabetes (T2D) consistently show attenuated weight reduction, even though glycemic improvement is clearly observed [2]. This observation suggests that, under diabetic conditions, pathways related to glycemic regulation are preferentially preserved, whereas those governing weight reduction are selectively constrained by a complex network of metabolic, cellular, and molecular mechanisms.

At the core of this limitation lies chronic insulin resistance (IR), a hallmark of metabolic rigidity. Persistently high insulin levels, or hyperinsulinemia, promote anabolic storage, inhibit lipolysis, and reduce resting metabolic rate, creating a metabolic “headwind” against fat loss [3]. Concurrently, adipose tissue dysfunction-manifested as hypertrophy, fibrosis, and inflammation-impairs tissue remodeling and restricts the plasticity essential for sustained weight loss [3]. Thus, while GLP-1RAs effectively reduce appetite, diabetic obesity can potentially diminish their ability to mobilize stored energy [2]. In other words, under metabolic stress, GLP-1 signaling appears to follow a biological “division of labor,” wherein receptor activation is preferentially directed toward glucose homeostasis-through increased insulin secretion from pancreatic β-cells and suppression of glucagon from pancreatic α-cells-while pathways involved in appetite control, lipolysis, and thermogenesis are only partially engaged.

This functional dissociation is further reinforced by multiple molecular and central mechanisms. IR in hypothalamic neurons that regulate appetite and energy homeostasis may blunt responsiveness to GLP-1 signaling, attenuating anorectic activity while maintaining glucose-lowering actions [4]. Sustained hyperglycemia and inflammation can create stable “epigenetic memory” through DNA methylation and histone modification, potentially locking IR into a chronic state and reducing metabolic flexibility [5]. Over time, prolonged metabolic stress may also downregulate GLP-1R expression in β-cells, adipose tissue, and the hypothalamus-compromising pathways that mediate weight loss but preserving those that regulate pancreatic glucose control.

Beyond these canonical mechanisms, several physiological adaptations may further constrain weight loss in T2D. Chronic diabetes is frequently associated with autonomic neuropathy and reduced vagal tone, impairing gut-brain communication crucial for GLP-1-mediated satiety [6]. Additionally, a pharmacodynamic “ceiling effect” may arise from persistently elevated endogenous GLP-1 levels, leading to receptor desensitization and reduced responsiveness to pharmacologic agonists [7]. The altered adipokine milieu-marked by elevated leptin and resisting levels and central leptin resistance-further dampens the synergistic interaction between GLP-1 and leptin signaling required for appetite suppression [8]. Moreover, enhanced adaptive thermogenesis reduces resting metabolic rate and offsets caloric restriction, while concurrent therapies such as insulin, sulfonylureas, or thiazolidinediones promote anabolic states that counteract the catabolic drive of incretin therapy [9,10].

Adding to these biological barriers, behavioral and cellular factors may further amplify the challenge. Fear of hypoglycemia may encourage excessive caloric intake, while physical inactivity-often a consequence of diabetic complications—reduces energy expenditure [11]. Mitochondrial dysfunction and oxidative stress impair fatty acid oxidation and ATP production, decreasing overall energy efficiency [12]. Compounding this, gut microbiome dysbiosis-characterized by reduced microbial diversity and enrichment of energy-harvesting, pro-inflammatory taxa-can blunt GLP-1 responsiveness by altering incretin signaling and amplifying systemic inflammation [13]. Collectively, these factors explain why glycemic control improves rapidly and predictably with GLP-1RAs, whereas weight loss tends to be slower, less consistent, and frequently dose-dependent.

Taken together, these interlinked mechanisms form a coherent framework that generates testable hypotheses and points toward new therapeutic strategies. Early initiation of GLP-1RA therapy may help preserve receptor responsiveness before downregulation and epigenetic inflexibility set in. Combination pharmacotherapy-for instance, pairing GLP-1RAs with SGLT2 (Sodium-Glucose Cotransporter 2) inhibitors or optimizing insulin regimens-may help mitigate hyperinsulinemia and enhance lipid mobilization [14]. Lifestyle interventions, including structured exercise and nutritional modulation, can counter adaptive thermogenesis and restore mitochondrial function [15,16]. Furthermore, innovative approaches targeting epigenetic rigidity or modifying the gut microbiome may enhance metabolic plasticity [17]. The development of dual or triple agonists targeting GLP-1, GIP, and glucagon receptors, along with precision-medicine strategies guided by metabolic phenotyping, could further help overcome adaptive resistance [18].

To this end, the relative attenuation of weight loss in T2D should not be interpreted as therapeutic failure but rather as an adaptive biological prioritization that favors glucose homeostasis over energy mobilization under metabolic stress. Recognizing and deliberately rebalancing this “division of labor” through integrated pharmacologic, behavioral, and molecular approaches may finally enable incretin-based therapies to achieve their full metabolic potential.

Declarations

Conflict of Interest

The author does have anything to declare.

Funding

This research is supported by Bandhan, Kolkata, India.

References

Collins, L., Costello, R. A. (2024). Glucagon-like peptide-1 receptor agonists. In StatPearls, StatPearls Publishing.
Publisher | Google Scholor
Cerchi, E., Santo, P. A. D. E., de Oliveira, M. C., Janovsky, C. C. P. S., Halpern, B. (2025). Effects of tirzepatide on weight management in patients with and without diabetes: a systematic review and meta-analysis: Clinical Research. International Journal of Obesity, 49(12):2415-2425.
Publisher | Google Scholor
Vargas, E., Joy, N. V., Sepulveda, M. A. C. (2022). Biochemistry, insulin metabolic effects. In StatPearls. StatPearls Publishing.
Publisher | Google Scholor
Park, J. S., Kim, K. S., Choi, H. J. (2025). Glucagon-like peptide-1 and hypothalamic regulation of satiation: cognitive and neural insights from human and animal studies. Diabetes & Metabolism Journal, 49(3):333-347.
Publisher | Google Scholor
Dong, H., Sun, Y., Nie, L., Cui, A., Zhao, P., et al. (2024). Metabolic memory: mechanisms and diseases. Signal Transduction and Targeted Therapy, 9(1):38.
Publisher | Google Scholor
Zhou, M. X., Zhao, Y., Chu, C. L., Behera, T. R., Shen, Q. Q., et al. (2025). Diabetic gastrointestinal autonomic neuropathy: Integrating neuronal degeneration and gut microbial dysbiosis. World Journal of Diabetes, 16(9):110053.
Publisher | Google Scholor
Slosky, L. M., Caron, M. G., Barak, L. S. (2021). Biased allosteric modulators: new frontiers in GPCR drug discovery. Trends in pharmacological Sciences, 42(4):283-299.
Publisher | Google Scholor
Hu, W., Zhu, H., Gong, F. (2025). Leptin and leptin resistance in obesity: current evidence, mechanisms and future directions. Endocrine Connections, 14(9).
Publisher | Google Scholor
Genchi, V. A., Palma, G., Sorice, G. P., D’Oria, R., Caccioppoli, C., et al. (2023). Pharmacological modulation of adaptive thermogenesis: new clues for obesity management? Journal of Endocrinological Investigation, 46(11):2213-2236.
Publisher | Google Scholor
Lopez Torres, S. Y., Aukan, M. I., Gower, B. A., Martins, C. (2024). Adaptive thermogenesis, at the level of resting energy expenditure, after diet alone or diet plus bariatric surgery. Obesity, 32(6):1169-1178.
Publisher | Google Scholor
Zahalka, S. J., Abushamat, L. A., Scalzo, R. L., Reusch, J. E. (2019). The role of exercise in diabetes.
Publisher | Google Scholor
Bhatti, J. S., Bhatti, G. K., Reddy, P. H. (2017). Mitochondrial dysfunction and oxidative stress in metabolic disorders-A step towards mitochondria based therapeutic strategies. Biochimica et biophysica acta (BBA)-Molecular Basis of Disease, 1863(5):1066-1077.
Publisher | Google Scholor
Zeng, Y., Wu, Y., Zhang, Q., Xiao, X. (2024). Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases. MBio, 15(1):e02032-23.
Publisher | Google Scholor
Gourdy, P., Darmon, P., Dievart, F., Halimi, J. M., Guerci, B. (2023). Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM). Cardiovascular Diabetology, 22(1):79.
Publisher | Google Scholor
Do, L. H., Da Costa, R. T., Solesio, M. E. (2025). Effects of nutrients and diet on mitochondrial dysfunction: An opportunity for therapeutic approaches in human disease. Biomedicine & Pharmacotherapy, 191:118493.
Publisher | Google Scholor
Ramos-Jiménez, A., Rubio-Valles, M., Ramos-Hernández, J. A., González-Rodríguez, E., Moreno-Brito, V. (2025). Adaptations in mitochondrial function induced by exercise: A therapeutic route for treatment-resistant depression. International Journal of Molecular Sciences, 26(17):8697.
Publisher | Google Scholor
Guo, S., Zhao, J., Zhu, R., Fan, Z., Liu, S., et al. (2025). Epigenetic modifications of gut microbiota and their potential role in atherosclerosis. Frontiers in Pharmacology, 16:1638240.
Publisher | Google Scholor
Zhang, J., Sanan, S., Csanalosi, M., Zheng, C., Pfeiffer, A. F. (2025). Novel dual and triple agonists targeting GLP-1, GIP, Glucagon, and GDF15 for type 2 diabetes and obesity management. Endocrinology, bqaf130.
Publisher | Google Scholor

Delia Teresa Sponza

"Journal of BioMed Research and Reports has created a diverse portfolio in peer review process and provides a wide range scientific and medical novel papers to the scientists. This journal publishes high-quality, peer-reviewed content across all levels of professional development and corporate research and development."

Fatema Tashrifwala

I would like to thank the editorial team for their timely responses and consideration in the publication of my paper. They have been very helpful and accommodating, Lastly, being an open access journal, the published work is freely available and accessible to readers at no cost to them. I would encourage other authors to publish their research in BioRes Scientia. I am happy to be a part of BioRes Scientia Publishers.

Dr Nikhil Vitthal Dayama

I would like to thank the editorial team for their timely and prompt responses and consideration in the publication of my case report. Being an open access journal, it will be great help for the readers to learn the new things without any cost. I would encourage the authors to publish their research in BioRes Scientia and I am happy to be part of this journal.

Boubacar Ahy Diatta

I warmly thank the editorial team for the excellent work they do for continuing medical education in Dermatology. I was able to discover with joy their professionalist, their support and above all appreciate their social generosity on the access to the magazines which is free. This allows an update of scientific knowledge to the entire scientific community. I gladly recommend authors for publication in this journal.

Professor Rajko Igic

The editor of JBRR helped me during the whole process, mainly to eliminate some typographical and other errors. It hastened this publication to be published quickly. Although it is a short text, I believe that the content is important for all medical and other scientific disciplines because eventual addition of the iC citations to citation of the paper would lead to proper assessment of the author's contribution.

Dr Tewodros kassahun Tarekegn

I am thrilled to have had the opportunity to publish my research article in this prestigious journal. The entire process of peer review and publication support provided by the editorial office was exceptional, and it fortified my belief in the quality of my research study. The rigorous peer review process ensured that only the highest quality research was published, and the feedback from the reviewers was extremely helpful. I appreciate the journal's commitment to open access publication, enabling my research to reach a wider audience. The easy-to-use online platform streamlined the submission, peer review, and publication process, and I would confidently recommend this journal to any author looking for efficient, rigorous, and high-quality peer-reviewed publication.

Francis Okello Ooko

I was impressed by your author-centred approach whereby you maintained constant and timely communication with us from the time we submitted the manuscript to acceptance, each time providing critical suggestions to improve the manuscript. In addition, we are encouraged by the thoroughness of your editorial team in checking the originality and overall, quality of the work. Which I believe is very encouraging to other researchers and authors who wish to publish their work in your journals. The published work and the information imparted is freely available and accessible to a wide spectrum of readers at no cost to them. I would encourage other authors to publish their research in BioRes Scientia. I am happy to be a part of BioRes Scientia Publishers.

Dr Nidhi Sapolia

I would like to thank the editorial team of their timely response and guidance in the publication of my case report. They have been extremely helpful at all stages. Being an open access journal, it is of great help for the readers to learn new experiences in different fields, I would highly recommend this journal to authors for high quality peer-reviewed publications.

Dwight L Mckee MD CNS ABIHM

I am very impressed by the high quality of the papers published by the International Journal of Clinical and Molecular Oncology. The editors of this journal are a pleasure to work with, as they are highly responsive even to numerous last minute changes in the manuscript that I recently published with them, and the changes are made on-line the same day they are received. I highly recommend this journal to anyone working in the oncology field, and also value it as a source of cutting edge information in the field.

Kyaw Swar Thet

I would like to thank the editorial team for the opportunity to publish our case report in this prestigious journal. I am very impressed by their timely and efficient handling of the submission, peer review, and publication processes. As residents of a developing, low-income country, we greatly appreciate the discount on submission charges. I hope that as an open access journal, it will facilitate easy access for readers to update their scientific knowledge. I highly recommend this journal for high-quality, peer-reviewed publications. I express my sincere gratitude to the editorial team for their excellent work.

Michel Farah

I would like to thank the editorial team for their quick response and support. The publication support and editorial office were excellent and very helpful. I am happy to have my research article published in this prestigious journal. Our previous case report published in this journal was very successful and viewed by many physicians worldwide.

Kristina Dimitrijevic

I am very positively surprised by thе International Journal of Biomedical and Clinical Research, as well as by the review process itself, which is carried out in a high-quality, timely and professional manner. I am glad that my articles are part of this journal.

Hamid Kasim

I had the pleasure of working with your esteemed journal. I testify that the peer review process was effective and quick, the support from the editorial office is very professional, respectful and friendly and the quality of the review is objective and accurate. I am grateful for the opportunity to work with International Journal of Biomedical & Clinical Research and looking forward for more future cooperation.

Ochala Ejura J

The interaction with the Journal of Women Health Care and Gynaecology has been seamless. I wish to express my profound appreciation to your expert editorial team for the timely response and support. The feedbacks from the peer review process was of great help. Thank you for the discount and opportunity to publish in your reputable journal. I believe that being an Open access journal, it will enable readers easy access to to update their knowledge. I would recommend BioRes Scientia publishers and look forward to more collaborations.

Fernando M Clara

I would like to thank the Journal of Clinical Cardiology and Cardiology Research for the opportunity to publish our work. We greatly appreciate the professionalism demonstrated throughout the editorial process. The rapid peer review, along with the high-quality graphic design, streamlined the process and significantly improved the final presentation of our manuscript. The Journal’s support for scientific dissemination is a meaningful incentive for ongoing research. We commend your editorial efforts and extend our best wishes for the Journal's continued success.

Dr Stylianos Sergios Chatziioannou

Journal of BioMed Research and Reports process was constructive and timely, ensuring that the scientific rigor of the manuscript was upheld. Communication with the editorial office was smooth and supportive throughout, making the overall publication experience very positive. I appreciate the efforts of the editorial team in maintaining high-quality standards, and I am confident that the journal will continue to grow in impact and recognition.

Dr C Zeroual

I am pleased to have worked with the Journal of Brain Research and Neurology. The editorial team was responsive and supportive throughout the process, and the peer review was handled efficiently. I appreciate the opportunity to contribute to this journal and look forward to future collaborations

Mohammadreza Kashefi Baher

I am pleased to have published my research in Dentistry and Oral Health Care. The peer review process was efficient and respectful, and I appreciated the timely communication and support from the editorial team. The journal maintains a professional standard and provides an accessible platform for sharing scientific work. I am grateful for the opportunity and look forward to contributing again in the future.

Cidalia De Fatima Cabral De Frias

I would like to thank the editorial team of International Journal of Biomedical and Clinical Research for their prompt and timely responses during the review process of my article. I had the opportunity to share with the academic community my understanding of the process of caring for a person at the end of life. I recommend the publication of research in the area of palliative care in this prestigious journal.

Roxana Maria Hoza

The peer review process at Hematology Research and Blood Disorders is fair and constructive. The editorial office provides excellent support and timely communication. The journal maintains high quality and is a trusted platform for hematology research.

Dr Hamid Kasim

I was very pleased to collaborate with your esteemed Journal of BioMed Research and Reports, and I also thank the editorial board and the reviewers who enriched my article with their very helpful comments, resulting in a beautiful and elegant presentation. I hope our collaboration will continue in the future, With my respect and best wishes for your continued success.

Dr Sabita Sinha

I would like to sincerely thank the editorial team for their excellent support and for handling the review process smoothly. The entire publication process was well organized and easy to follow. My special thanks go to Katherine Bailey Ma'am for her continuous guidance and support from article submission to publication. Her assistance made the experience very positive and encouraging. I truly enjoyed the process and would highly recommend this Journal of BioMed Research and Reports to other researchers.

Jerome H Check

Clinical Case Reports and Studies peer review is rigorous and constructive, improving clarity and methodology. The editorial office is professional and responsive, with a user-friendly submission system and helpful language-editing support. Overall, the journal maintains high editorial standards and offers strong visibility for clinical research.

M Chandramohan

Our experience with the journal has been highly professional and rewarding. The peer review process was rigorous, transparent, and constructive, providing valuable insights that significantly strengthened the quality of our manuscript. The editorial office offered exceptional support throughout the submission and publication journey, ensuring timely communication and clear guidance at every stage. Their responsiveness and attention to detail made the entire process smooth and efficient. Overall, the journal maintains a high standard of scientific quality and integrity, making it a credible and respected platform for disseminating research. We truly appreciate the commitment to excellence demonstrated by the entire editorial team.